Clinical Trials Logo

Clinical Trial Summary

The primary aim of the current proposal is to evaluate safety and tolerability, in terms of neuropsychological effects of low frequency electrical stimulation of the fornix (LFSF) in participants with medically-intractable Mesial Temporal Lobe Epilepsy. Secondary aims include evaluation of psychiatric changes, seizure frequency, and quality of life during LFSF.


Clinical Trial Description

Low frequency stimulation is an attractive, uninvestigated method for treatment of intractable epilepsy. Preliminary animal and human data suggest safety and remarkable efficacy of Low frequency stimulation (LFS) in epilepsy. In addition, the duty cycle of LFS is very low, implying less electric current injection, with less charge density on the target tissue and electrodes, and longer battery life. The current project is a classic translational, single-blinded, randomized research project, demonstrating a clear path from the laboratory to bedside. If successful, this new therapy will be of great value to patients with medically and surgically intractable Mesial Temporal Lobe Epilepsy (MTLE). The study is expected to last approximately 5 years, from enrollment of the first patient to completion of the final subject, taking into consideration attrition and otherwise-eligible subjects who will not elect to participate. Once the study is completed, and enrolled participants have completed all required elements of the protocol, a final report will be submitted to the FDA. Participants may also discontinue their participation in the study, if they wish, at any time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02383407
Study type Interventional
Source George Washington University
Contact
Status Completed
Phase N/A
Start date December 2013
Completion date January 2019

See also
  Status Clinical Trial Phase
Terminated NCT04710004 - Electrophysiological Biomarkers in MTLE Patients. N/A
Recruiting NCT06063850 - AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy Phase 1/Phase 2
Recruiting NCT05608408 - PRIME: PReservIng Memory in Epilepsy N/A